Neuroendocrine markers of CNS drug effects.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D002491:Central Nervous System Agents / Q000494:pharmacology*; D003533:Cyproheptadine / Q000009:adverse effects; D004298:Dopamine / Q000502:physiology; D004702:Endocrine Glands / Q000187:drug effects*; D006801:Humans; D008094:Lithium / Q000009:adverse effects; D001523:Mental Disorders / Q000188:drug therapy; D009420:Nervous System / Q000187:drug effects*; D011957:Receptors, Opioid / Q000187:drug effects; D019966:Substance-Related Disorders / Q000503:physiopathology; D013569:Synapses / Q000187:drug effects
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002491:Central Nervous System Agents; D011957:Receptors, Opioid; D003533:Cyproheptadine; D008094:Lithium; D004298:Dopamine